Clinical trial
Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation
NCT02575183 is registered in ClinicalTrials.gov with American University of Beirut Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation
- Lead sponsor
- American University of Beirut Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- March 1, 2021
- Enrollment
- 152 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
nicotine dependence